Cite
Carter P, Alifrangis C, Cereser B, et al. Correction: Does molecular profiling of tumors using the Caris molecular intelligence platform improve outcomes for cancer patients?. Oncotarget. 2018;9(19):15166doi: 10.18632/oncotarget.24691.
Carter, P., Alifrangis, C., Cereser, B., Chandrasinghe, P., Del Bel Belluz, L., Herzog, T., Levitan, J., Moderau, N., Schwartzberg, L., Tabassum, N., Wen, J., Krell, J., & Stebbing, J. (2018). Correction: Does molecular profiling of tumors using the Caris molecular intelligence platform improve outcomes for cancer patients?. Oncotarget, 9(19), 15166. https://doi.org/10.18632/oncotarget.24691
Carter, Philip, et al. "Correction: Does molecular profiling of tumors using the Caris molecular intelligence platform improve outcomes for cancer patients?." Oncotarget vol. 9,19 (2018): 15166. doi: https://doi.org/10.18632/oncotarget.24691
Carter P, Alifrangis C, Cereser B, Chandrasinghe P, Del Bel Belluz L, Herzog T, Levitan J, Moderau N, Schwartzberg L, Tabassum N, Wen J, Krell J, Stebbing J. Correction: Does molecular profiling of tumors using the Caris molecular intelligence platform improve outcomes for cancer patients?. Oncotarget. 2018 Mar 13;9(19):15166. doi: 10.18632/oncotarget.24691. eCollection 2018 Mar 13. PMID: 29601070; PMCID: PMC5871109.
Copy
Download .nbib